Figure 2.
Patient disposition. The flowchart shows the number of patients included in each cohort from the FRAME and FRAME Extension trials after primary PSW and sensitivity analyses using PSW-MI and PSM. Abbreviations: DMAb = denosumab; MI = multiple imputation; PSM = propensity score matching; PSW = propensity score weighting; Romo = romosozumab.